Stocks
Revvity, Inc.

Revvity, Inc.RVTY

NYSEHealthcareDiagnostics & Research$161.86+0.96%

Price as of · delayed, not real-time

Formerly known as PerkinElmer, Revvity is a provider of life sciences and diagnostics solutions, offering analytical instruments, reagents, and software to research and clinical markets. The company is tracked by investors for its exposure to high-growth areas like genomics, diagnostics, and drug discovery tools.

Market Cap: $9.7B52W Range: $81.22-$166.25

Congressional Interest in Revvity, Inc. (RVTY)

7 members of Congress have disclosed 38 trades in Revvity, Inc. (RVTY), a Healthcare company. The buy/sell breakdown shows 19 purchases versus 19 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.

Total Disclosures
38
Unique Politicians
7
Buys
19
Sells
19

Who in Congress Is Trading RVTY?

2026-09-09$15K-$50K
Stock
2026-09-04$1K-$15K
Stock
2026-09-03$1K-$15K
Stock
2026-06-30$1K-$15K
Stock
2026-05-15$1K-$15K
Stock
2026-05-04$15K-$50K
Stock
2026-05-01$1K-$15K
Stock
2026-04-13$1K-$15K
Stock
2026-02-05$1K-$15K
Stock
2026-01-29$1K-$15K
Stock
2025-09-12$1K-$15K
Stock
2025-08-13$1K-$15K
Stock
2025-07-23$1K-$15K
Stock
2025-07-22$1K-$15K
Stock
2025-06-17$1K-$15K
Stock
2025-06-11$1K-$15K
Stock
2025-05-28$1K-$15K
Stock
2025-05-28$1K-$15K
Stock
2025-04-23$1K-$15K
Stock
2025-04-08$1K-$15K
Stock
2025-03-06$1K-$15K
Stock
2025-02-28$15K-$50K
Stock
2025-02-25$1K-$15K
Stock
2025-02-19$1K-$15K
Stock
2024-11-15$1K-$15K
Stock
2024-05-05$1K-$15K
Stock
2024-04-25$1K-$15K
Stock
2023-11-03$1K-$15K
Stock
2023-10-02$1K-$15K
Stock
2023-06-26$1K-$15K
Stock
2022-11-03$1K-$15K
Stock
2022-05-09$1K-$15K
Stock
2018-12-04$1K-$15K
Stock
2018-06-21$1K-$15K
Stock
2018-05-02$1K-$15K
Stock
2018-02-06$1K-$15K
Stock
2017-08-02$1K-$15K
Stock
2017-06-20$15K-$50K
Stock